SE420834B - Analogiforfarande for framstellning av beta-receptoraktiva derivat av 2-hydroxi-3-aminopropan - Google Patents

Analogiforfarande for framstellning av beta-receptoraktiva derivat av 2-hydroxi-3-aminopropan

Info

Publication number
SE420834B
SE420834B SE7401114A SE7401114A SE420834B SE 420834 B SE420834 B SE 420834B SE 7401114 A SE7401114 A SE 7401114A SE 7401114 A SE7401114 A SE 7401114A SE 420834 B SE420834 B SE 420834B
Authority
SE
Sweden
Prior art keywords
aminopropan
beta
hydroxy
preparation
active derivatives
Prior art date
Application number
SE7401114A
Other languages
English (en)
Swedish (sv)
Inventor
J Frei
K A Jaeggi
F Ostermayer
H Schroter
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH244473A external-priority patent/CH584209A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE420834B publication Critical patent/SE420834B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7401114A 1973-02-20 1974-01-29 Analogiforfarande for framstellning av beta-receptoraktiva derivat av 2-hydroxi-3-aminopropan SE420834B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH244473A CH584209A5 (en) 1973-02-20 1973-02-20 3-amino-2-hydroxypropoxy substd. diazines and pyridines - with beta-adrenergic blocking or stimulating activity
FI193/74A FI60391C (fi) 1973-02-20 1974-01-23 Analogifoerfarande foer framstaellning av beta-reseptor-aktiva 1-heterocyklyloxi-3-amino-2-propanolfoereningar

Publications (1)

Publication Number Publication Date
SE420834B true SE420834B (sv) 1981-11-02

Family

ID=25690464

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7401114A SE420834B (sv) 1973-02-20 1974-01-29 Analogiforfarande for framstellning av beta-receptoraktiva derivat av 2-hydroxi-3-aminopropan

Country Status (15)

Country Link
AR (6) AR206801A1 (es)
AT (1) AT335455B (es)
BE (1) BE811274A (es)
CA (1) CA1027131A (es)
CS (1) CS203970B2 (es)
DD (1) DD110041A5 (es)
DE (1) DE2406930A1 (es)
DK (1) DK143501C (es)
ES (2) ES446081A1 (es)
FR (1) FR2218101B1 (es)
GB (1) GB1465946A (es)
IE (1) IE38839B1 (es)
IL (1) IL44202A (es)
LU (1) LU69415A1 (es)
SE (1) SE420834B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
US4000282A (en) * 1974-12-16 1976-12-28 Merck & Co., Inc. 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
JPS5283759A (en) * 1976-01-01 1977-07-12 Merck & Co Inc Substituted pyridines
US4060601A (en) * 1976-06-15 1977-11-29 Merck & Co., Inc. Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines
US4091104A (en) * 1976-06-15 1978-05-23 Merck & Co., Inc. Substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines, their preparation and use
US4092419A (en) * 1976-06-15 1978-05-30 Merck & Co., Inc. Substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines, their preparation and use
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4166851A (en) * 1977-05-16 1979-09-04 Merck & Co., Inc. Certain imidazo(1,2a)pyridine derivatives
US4753673A (en) * 1977-07-22 1988-06-28 The Dow Chemical Company Trifluoromethyl pyridinyloxyphenoxy and pyridinylthiophenoxy propanoic acids and propanols and derivatives thereof and methods of herbicidal use
US4144343A (en) * 1978-01-04 1979-03-13 Merck & Co., Inc. Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines
US4279913A (en) * 1978-01-04 1981-07-21 Merck & Co., Inc. Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines
JPS54106476A (en) * 1978-01-04 1979-08-21 Merck & Co Inc Multiisubstituted 22*33lower alkylaminoo22 r100propoxy*pyridine
US4208416A (en) * 1978-06-27 1980-06-17 Merck & Co., Inc. N-Aralkyl containing cyanopyridines
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
DK267779A (da) * 1978-06-27 1979-12-28 Merck & Co Inc Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner
US4294969A (en) * 1979-01-29 1981-10-13 Merck & Co., Inc. Process for producing 2-bromo-3,5-disubstituted pyridines
US4393212A (en) * 1979-01-29 1983-07-12 Merck & Co., Inc. Certain nicotinic acid esters and corresponding nicotinonitriles
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
US4281005A (en) 1979-03-05 1981-07-28 Merck & Co., Inc. Novel 2-pyridylimidazole compounds
IT1165040B (it) * 1979-04-23 1987-04-22 Isf Spa Alcossialchilidenidrazinopiridazione e procedimento per la loro preparazione
DE2943774A1 (de) * 1979-10-26 1981-05-14 1000 Berlin Schering Ag Berlin Und Bergkamen Substituierte pyridine, verfahren zu ihrer herstellung und ihre verwendung
IL62602A (en) * 1980-05-19 1984-06-29 Labaz Sanofi Nv Pyridoxine derivatives,their preparation and pharmaceutical compositions containing them
FR2502618A1 (fr) * 1981-03-25 1982-10-01 Synthelabo Derives de pyridine, leur preparation et leur application en therapeutique
US4517188A (en) * 1983-05-09 1985-05-14 Mead Johnson & Company 1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols
US4598149A (en) * 1984-03-02 1986-07-01 Merck & Co., Inc. 3-amino-2-hydroxypropyl of pyrimidin-4-one useful as antihypertensive, cardioprotective, antiarrythmic, and antianginal agents
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US7361671B2 (en) * 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids
ATE454383T1 (de) 2002-06-19 2010-01-15 Biovitrum Ab Publ Neue verbindungen, deren verwendung und herstellung
MXPA05005661A (es) * 2002-11-27 2005-11-23 Artesian Therapeutics Inc Compuestos con actividad antagonista o antagonista parcial mixta inhibidora de fosfodiesterasa y beta-adrenergica para el tratamiento de insuficiencia cardiaca.
JP2008507491A (ja) * 2004-07-23 2008-03-13 バイエル・クロツプサイエンス・エス・アー 殺真菌剤としての3−ピリジニルエチルベンズアミド誘導体
BR112012006330A2 (pt) * 2009-09-21 2017-07-04 Janssen Cilag S A análogos de o-benzil nicotinamida como moduladores alostéricos positivos de mglur5

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1001631A (en) * 1972-05-05 1976-12-14 Merck Sharp And Dohme (I.A.) Corp. 2-(3-substituted amino-2-hydroxy-propoxy)-3-substituted pyrazines and method for preparation

Also Published As

Publication number Publication date
IE38839B1 (en) 1978-06-07
DK143501B (da) 1981-08-31
DD110041A5 (es) 1974-12-05
IL44202A0 (en) 1974-06-30
AR208397A1 (es) 1976-12-27
CA1027131A (en) 1978-02-28
LU69415A1 (es) 1975-12-09
AR208043A1 (es) 1976-11-22
AT335455B (de) 1977-03-10
IE38839L (en) 1974-08-20
AR206801A1 (es) 1976-08-23
CS203970B2 (en) 1981-03-31
DK143501C (da) 1982-02-22
ATA133074A (de) 1976-07-15
AR214612A1 (es) 1979-07-13
AR203878A1 (es) 1975-10-31
DE2406930A1 (de) 1974-08-22
IL44202A (en) 1978-10-31
FR2218101A1 (es) 1974-09-13
GB1465946A (en) 1977-03-02
FR2218101B1 (es) 1977-07-15
BE811274A (fr) 1974-08-19
ES446081A1 (es) 1977-06-16
ES446083A1 (es) 1977-09-16
AR207133A1 (es) 1976-09-15

Similar Documents

Publication Publication Date Title
SE420834B (sv) Analogiforfarande for framstellning av beta-receptoraktiva derivat av 2-hydroxi-3-aminopropan
SE424320B (sv) Analogiforfarande for framstellning av derivat av 3-sulfonamido-4-amino-pyridiner
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
SE417199B (sv) Analogiforfarande for framstellning av etanolaminderivat
SE413405B (sv) Analogiforfarande for framstellning av pyridazinonforeningar
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
SE431872B (sv) Analogiforfarande for framstellning av derivat av 4-pyrimidon
SE424324B (sv) Analogiforfarande for framstellning av 1,2-benzisoxazolderivat
SE420598B (sv) Analogiforfarande for framstellning av naftalenderivat
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE421418B (sv) Forfarande for framstellningav pyridinderivat
SE415834B (sv) Analogiforfarande for framstellning av pyrazolderivat
SE410470B (sv) Forfarande for framstellning av xyloslosning
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
SE413404B (sv) Forfarande for framstellning av pyrazolderivat
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
SE420312B (sv) Forfarande for framstellning av pyridinnitril
SE385583B (sv) Forfarande for framstellning av nya terapeutiskt aktiva derivat av isoindolin
SE416648B (sv) Forfarande for framstellning av pyrazoler
SE419543B (sv) Forfarande for framstellning av vissa angivna isokinolinderivat
SE417825B (sv) Analogiforfarande for framstellning av derivat av antibiotikum xk-62-2
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE415835B (sv) Forfarande for framstellning av basiskt substituerade derivat av 4-hydroxi-bensimidazol
SE424638B (sv) Analogiforfarande for framstellning av 5,7-dihydroxi-tetrahydroisokinolin derivat
NO140344C (no) Fremgangsmaate for fremstilling av nye n2-dansyl-l-argininderivater